During the past decade, Stanley Street Treatment and Resources conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 9 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Stanley Street Treatment and Resources" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 7 trials, followed by "Indivior Inc." with 4 trials sponsored, "NYU Langone Health" with 3 trials sponsored, "Titan Pharmaceuticals" with 3 trials sponsored and "Braeburn Pharmaceuticals" with 3 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Stanley Street Treatment and Resources" #1 collaborator was "National Institute on Drug Abuse (NIDA)" with 5 trials as a collaborator, "The Emmes Company, LLC" with 2 trials as a collaborator, "Columbia University" with 1 trials as a collaborator, "Harvard Medical School (HMS and HSDM)" with 1 trials as a collaborator and "Mclean Hospital" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Stanley Street Treatment and Resources" are "HIV Infections" (9 trials), "Opioid Use Disorder" (5 trials), "Opioid Dependence" (3 trials), "Opioid-related Disorders" (3 trials) and "Opioid-Related Disorders" (2 trials). Many other conditions were trialed in "Stanley Street Treatment and Resources" in a lesser frequency.

Most popular intervention types in "Stanley Street Treatment and Resources" are "Drug" (15 trials), "Behavioral" (8 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "RBP-6000" (3 trials), "Probuphine (buprenorphine implant)" (2 trials), "A-CHESS" (1 trials), "Alendronate" (1 trials) and "Atazanavir" (1 trials). Other intervention names were less common.

The vast majority of trials in "Stanley Street Treatment and Resources" are 26 trials for "All" genders.

Currently, there are NaN active trials in "Stanley Street Treatment and Resources". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Stanley Street Treatment and Resources, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Stanley Street Treatment and Resources, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 7 trials that are defined as “Not Applicable".